Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery

Fig. 2

No significant differences were observed in median PRS between Mt and Wt; median PRS were 33.9 months and 28.2 months, respectively (p = 0.360, Fig. 2a). PRS was significantly better in Mt with EGFR - TKI than in Wt and Mt patients without EGFR - TKI (p = 0.008 and p < 0.001, respectively). PRS was also significantly better in Wt than in Mt patients without EGFR - TKI (p < 0.001, Fig. 2b)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us